Our data complements a number of previous studies showing cognitive deficits in patients with serum NMDAR1-abs of primarily the IgA and IgM isotypes,[5, 7, 8, 28, 35] supporting the pathogenic effects of these antibodies beyond the acute encephalitis spectrum. This evidence concerns the gene CD79A and Cognitive impairment.